From Diabetes to Metabolic Syndrome: A View Point on An Evolving Concept

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|25|2580-2583

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.25, 2007-09, pp. : 2580-2583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe improves lipid profiles in diabetes and metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The professional deformation of the personality from the point of view of deontology

By Ternovsky L.N.   Ternovskaya V.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 363-363

Elsevier

Access to resources Recommend Favorite

Khat Chewing from the Pharmacological Point of View: An Update

By Graziani Manuela   Milella Michele   Nencini Paolo  

Substance Use & Misuse, Vol. 43, Iss. 6, 2008-05 ,pp. : 762-783

Informa Healthcare

Access to resources Recommend Favorite

Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies

By Chan Dick C   Watts Gerald F  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 13-30

Informa Healthcare

Access to resources Recommend Favorite

Fine Tuning of PPAR Ligands for Type 2 Diabetes and Metabolic Syndrome

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-01 ,pp. : 563-573

Bentham Science Publishers

Access to resources Recommend Favorite